30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Bicycle Therapeutics PLC (BCYC)

Track

Over the last 90 days, Bicycle Therapeutics PLC has seen significant insider selling, with a net value of -$682,981.9 and a net count of -5 executives. Total sales amounted to $166,777.71, with no recorded purchases. This activity occurred following a recent earnings report that missed expectations by 29.85%. The stock price has declined 21.9% over the past 90 days.
Stock chart
Ticker: BCYC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lee Kevin
CHIEF EXECUTIVE OFFICER
1 sale — total 8,666 USD
Sale 6 Apr 2026
Value US$3,316,799.99 | Price 498.86 | Shares 88,407
Sale 6 Apr 2026
Value US$3,131,661.87 | Price 42.23 | Shares 36,052
Sale 6 Apr 2026
Value US$515.10 | Price 5.05 | Shares 102
Sale 6 Apr 2026
Value US$1,267.55 | Price 5.05 | Shares 251
Planned sale 6 Apr 2026
Value US$1,678.32 | Price 5.04 | Shares 333
Sale 6 Apr 2026
Value US$186.85 | Price 5.05 | Shares 37
Sale 2 Apr 2026
Value US$29,297.97 | Price 4.91 | Shares 5,967
Proposed sale 2 Apr 2026
Value US$39,242.40 | Price 4.91 | Shares 8,000
Sale 2 Apr 2026
Value US$9,225.89 | Price 4.91 | Shares 1,879
Proposed sale 2 Apr 2026
Value US$12,263.25 | Price 4.91 | Shares 2,500
Sale 2 Apr 2026
Value US$3,923.09 | Price 4.91 | Shares 799
Proposed sale 2 Apr 2026
Value US$4,905.30 | Price 4.91 | Shares 1,000
Sale 2 Apr 2026
Value US$7,468.11 | Price 4.91 | Shares 1,521
Proposed sale 2 Apr 2026
Value US$9,074.81 | Price 4.91 | Shares 1,850
Sale 2 Apr 2026
Value US$5,096.58 | Price 4.91 | Shares 1,038
Proposed sale 2 Apr 2026
Value US$7,357.95 | Price 4.91 | Shares 1,500
Proposed sale 2 Apr 2026
Value US$9,977.38 | Price 4.91 | Shares 2,034
Proposed sale 2 Apr 2026
Value US$13,980.11 | Price 4.91 | Shares 2,850
Sale 5 Jan 2026
Value US$21,098.36 | Price 6.46 | Shares 3,266
Sale 5 Jan 2026
Value US$22,067.36 | Price 6.46 | Shares 3,416
Sale 5 Jan 2026
Value US$15,267.15 | Price 6.45 | Shares 2,367
Planned sale 5 Jan 2026
Value US$12,282.12 | Price 6.54 | Shares 1,878
Sale 5 Jan 2026
Value US$15,841.20 | Price 6.45 | Shares 2,456
Proposed sale 5 Jan 2026
Value US$803.00 | Price 6.53 | Shares 123
Sale 5 Jan 2026
Value US$70,988.94 | Price 6.46 | Shares 10,989
Sale 5 Jan 2026
Value US$7,191.75 | Price 6.45 | Shares 1,115
Sale 2 Jan 2026
Value US$20,706.00 | Price 6.80 | Shares 3,045
Proposed sale 2 Jan 2026
Value US$43,507.00 | Price 6.80 | Shares 6,400
Sale 2 Jan 2026
Value US$22,059.20 | Price 6.80 | Shares 3,244
Proposed sale 2 Jan 2026
Value US$46,850.00 | Price 6.94 | Shares 6,750
Sale 2 Jan 2026
Value US$19,223.60 | Price 6.80 | Shares 2,827
Proposed sale 2 Jan 2026
Value US$35,690.00 | Price 6.80 | Shares 5,250
Sale 2 Jan 2026
Value US$22,365.20 | Price 6.80 | Shares 3,289
Proposed sale 2 Jan 2026
Value US$50,985.00 | Price 6.80 | Shares 7,500
Sale 2 Jan 2026
Value US$70,210.00 | Price 6.80 | Shares 10,325
Proposed sale 2 Jan 2026
Value US$146,157.00 | Price 6.80 | Shares 21,500
Sale 2 Jan 2026
Value US$8,955.60 | Price 6.80 | Shares 1,317
Proposed sale 2 Jan 2026
Value US$18,695.00 | Price 6.80 | Shares 2,750
Sale 3 Oct 2025
Value US$866.23 | Price 8.41 | Shares 103
Sale 3 Oct 2025
Value US$8,224.98 | Price 8.41 | Shares 978
Sale 3 Oct 2025
Value US$8,224.98 | Price 8.41 | Shares 978
Sale 3 Oct 2025
Value US$2,102.50 | Price 8.41 | Shares 250
Sale 3 Oct 2025
Value US$27,172.71 | Price 8.41 | Shares 3,231
Sale 2 Oct 2025
Value US$1,856.40 | Price 8.40 | Shares 221
Proposed sale 2 Oct 2025
Value US$4,563.00 | Price 8.40 | Shares 543
Planned sale 2 Oct 2025
Value US$872.10 | Price 8.55 | Shares 102
Proposed sale 2 Oct 2025
Value US$872.00 | Price 8.55 | Shares 102
Sale 2 Oct 2025
Value US$6,921.60 | Price 8.40 | Shares 824
Planned sale 2 Oct 2025
Value US$2,280.32 | Price 8.61 | Shares 265
Sale 2 Oct 2025
Value US$1,822.80 | Price 8.40 | Shares 217
Proposed sale 2 Oct 2025
Value US$3,447.00 | Price 7.09 | Shares 486
Sale 2 Oct 2025
Value US$9,634.80 | Price 8.40 | Shares 1,147
Proposed sale 2 Oct 2025
Value US$19,023.00 | Price 8.40 | Shares 2,264
Sale 2 Oct 2025
Value US$3,973.20 | Price 8.40 | Shares 473
Proposed sale 2 Oct 2025
Value US$6,344.00 | Price 8.40 | Shares 755
Sale 2 Oct 2025
Value US$19,009.20 | Price 8.40 | Shares 2,263
Proposed sale 2 Oct 2025
Value US$50,061.00 | Price 8.40 | Shares 5,958
Sale 3 Jul 2025
Value US$23,755.92 | Price 7.44 | Shares 3,193
Sale 3 Jul 2025
Value US$744.00 | Price 7.44 | Shares 100
Sale 3 Jul 2025
Value US$1,845.12 | Price 7.44 | Shares 248
Sale 3 Jul 2025
Value US$7,187.04 | Price 7.44 | Shares 966
Sale 3 Jul 2025
Value US$7,187.04 | Price 7.44 | Shares 966
Sale 2 Jul 2025
Value US$16,080.12 | Price 7.09 | Shares 2,268
Proposed sale 2 Jul 2025
Value US$42,287.00 | Price 7.09 | Shares 5,963
Sale 2 Jul 2025
Value US$1,460.54 | Price 7.09 | Shares 206
Proposed sale 2 Jul 2025
Value US$3,760.00 | Price 7.09 | Shares 530
Sale 2 Jul 2025
Value US$1,446.36 | Price 7.09 | Shares 204
Proposed sale 2 Jul 2025
Value US$1,461.00 | Price 7.09 | Shares 206
Sale 2 Jul 2025
Value US$3,360.66 | Price 7.09 | Shares 474
Proposed sale 2 Jul 2025
Value US$5,358.00 | Price 7.09 | Shares 756
Sale 2 Jul 2025
Value US$5,849.25 | Price 7.09 | Shares 825
Proposed sale 2 Jul 2025
Value US$13,769.00 | Price 7.09 | Shares 1,942
Sale 2 Jul 2025
Value US$8,146.41 | Price 7.09 | Shares 1,149
Proposed sale 2 Jul 2025
Value US$16,066.00 | Price 7.09 | Shares 2,266
Sale 3 Apr 2025
Value US$25,671.36 | Price 7.48 | Shares 3,432
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-06 2026-04-06 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
88,407 -44.0%
498.86
US$3,316,800 		88,407 -44.0% 498.86 US$3,316,800
2026-04-06 2026-04-06 S Sale
3.7
Skynner Michael

CHIEF SCIENTIFIC OFFICER

Officer
36,052 +33.1%
42.23
US$3,131,662 		36,052 +33.1% 42.23 US$3,131,662
2026-04-06 2026-04-06 S Sale
3.9
Thompson Travis Alvin

Chief Financial Officer

Officer
39,675 +22.1%
376.78
US$245,963 		39,675 +22.1% 376.78 US$245,963
2026-04-06 2026-04-06 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
251 -0.3%
5.05
US$1,268 		251 -0.3% 5.05 US$1,268
2026-04-06 2026-04-06 PlS Planned sale
Perry Jennifer Scott

Chief Operating Officer

Officer
333 -0.4%
5.04
US$1,678 		333 -0.4% 5.04 US$1,678
2026-04-06 2026-04-06 S Sale
Perry Jennifer Scott

Chief Operating Officer

Officer
37 -0.0%
5.05
US$187 		37 -0.0% 5.05 US$187
2026-04-06 2026-04-02 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
5,967 -1.0%
4.91
US$29,298 		5,967 -1.0% 4.91 US$29,298
2026-04-06 2026-04-02 S Sale
3.7
Skynner Michael

CHIEF SCIENTIFIC OFFICER

Officer
1,879 -1.2%
4.91
US$9,226 		1,879 -1.2% 4.91 US$9,226
2026-04-06 2026-04-02 S Sale
3.9
Thompson Travis Alvin

Chief Financial Officer

Officer
799 -1.2%
4.91
US$3,923 		799 -1.2% 4.91 US$3,923
2026-04-06 2026-04-02 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
1,521 -1.6%
4.91
US$7,468 		1,521 -1.6% 4.91 US$7,468
2026-04-06 2026-04-02 S Sale
Perry Jennifer Scott

Chief Operating Officer

Officer
1,038 -1.1%
4.91
US$5,097 		1,038 -1.1% 4.91 US$5,097
2026-04-02 2026-04-02 PrS Proposed sale
4.2
Young Alethia

Officer

Officer
2,034
4.91
US$9,977 		2,034 4.91 US$9,977
2026-04-02 2026-04-02 PrS Proposed sale
Perry Jennifer Scott

Officer

Officer
1,500
4.91
US$7,358 		1,500 4.91 US$7,358
2026-04-02 2026-04-02 PrS Proposed sale
3.9
Hannay Michael Charles Ferguson

Officer

Officer
1,850
4.91
US$9,075 		1,850 4.91 US$9,075
2026-04-02 2026-04-02 PrS Proposed sale
3.9
Thompson Travis Alvin

Officer

Officer
1,000
4.91
US$4,905 		1,000 4.91 US$4,905
2026-04-02 2026-04-02 PrS Proposed sale
3.7
Skynner Michael

Officer

Officer
2,500
4.91
US$12,263 		2,500 4.91 US$12,263
2026-04-02 2026-04-02 PrS Proposed sale
3.8
Milnes Alistair

Officer

Officer
2,850
4.91
US$13,980 		2,850 4.91 US$13,980
2026-04-02 2026-04-02 PrS Proposed sale
3.7
Lee Kevin

Officer

Officer
8,000
4.91
US$39,242 		8,000 4.91 US$39,242
2026-01-06 2026-01-05 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
3,266 -2.0%
6.46
US$21,098 		3,266 -2.0% 6.46 US$21,098
2026-01-06 2026-01-05 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
3,416 -2.4%
6.46
US$22,067 		3,416 -2.4% 6.46 US$22,067
2026-01-06 2026-01-05 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
2,367 -2.4%
6.45
US$15,267 		2,367 -2.4% 6.45 US$15,267
2026-01-06 2026-01-05 PlS Planned sale
4.2
Young Alethia

Chief Financial Officer

Officer
1,878 -2.1%
6.54
US$12,282 		1,878 -2.1% 6.54 US$12,282
2026-01-06 2026-01-05 S Sale
4.2
Young Alethia

Chief Financial Officer

Officer
2,456 -2.7%
6.45
US$15,841 		2,456 -2.7% 6.45 US$15,841
2026-01-06 2026-01-05 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
10,989 -1.7%
6.46
US$70,989 		10,989 -1.7% 6.46 US$70,989
2026-01-06 2026-01-05 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
1,115 -1.7%
6.45
US$7,192 		1,115 -1.7% 6.45 US$7,192
2026-01-05 2026-01-05 PrS Proposed sale
4.2
Young Alethia

Officer

Officer
123
6.53
US$803 		123 6.53 US$803
2026-01-06 2026-01-02 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
3,045 -1.8%
6.80
US$20,706 		3,045 -1.8% 6.80 US$20,706
2026-01-06 2026-01-02 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
3,244 -2.3%
6.80
US$22,059 		3,244 -2.3% 6.80 US$22,059
2026-01-06 2026-01-02 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
2,827 -2.7%
6.80
US$19,224 		2,827 -2.7% 6.80 US$19,224
2026-01-06 2026-01-02 S Sale
4.2
Young Alethia

Chief Financial Officer

Officer
3,289 -3.5%
6.80
US$22,365 		3,289 -3.5% 6.80 US$22,365
2026-01-06 2026-01-02 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
10,325 -1.6%
6.80
US$70,210 		10,325 -1.6% 6.80 US$70,210
2026-01-06 2026-01-02 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
1,317 -1.9%
6.80
US$8,956 		1,317 -1.9% 6.80 US$8,956
2026-01-02 2026-01-02 PrS Proposed sale
3.8
Milnes Alistair

Officer

Officer
6,750
6.94
US$46,850 		6,750 6.94 US$46,850
2026-01-02 2026-01-02 PrS Proposed sale
3.7
Skynner Michael

Officer

Officer
6,400
6.80
US$43,507 		6,400 6.80 US$43,507
2026-01-02 2026-01-02 PrS Proposed sale
3.9
Thompson Travis Alvin

Officer

Officer
2,750
6.80
US$18,695 		2,750 6.80 US$18,695
2026-01-02 2026-01-02 PrS Proposed sale
4.2
Young Alethia

Officer

Officer
7,500
6.80
US$50,985 		7,500 6.80 US$50,985
2026-01-02 2026-01-02 PrS Proposed sale
3.9
Hannay Michael Charles Ferguson

Officer

Officer
5,250
6.80
US$35,690 		5,250 6.80 US$35,690
2026-01-02 2026-01-02 PrS Proposed sale
3.7
Lee Kevin

Officer

Officer
21,500
6.80
US$146,157 		21,500 6.80 US$146,157
2025-10-06 2025-10-03 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
103 -0.3%
8.41
US$866 		103 -0.3% 8.41 US$866
2025-10-06 2025-10-03 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
978 -0.8%
8.41
US$8,225 		978 -0.8% 8.41 US$8,225
2025-10-06 2025-10-03 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
978 -1.0%
8.41
US$8,225 		978 -1.0% 8.41 US$8,225
2025-10-06 2025-10-03 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
250 -0.5%
8.41
US$2,102 		250 -0.5% 8.41 US$2,102
2025-10-06 2025-10-03 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
3,231 -0.7%
8.41
US$27,173 		3,231 -0.7% 8.41 US$27,173
2025-10-06 2025-10-02 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
221 -0.7%
8.40
US$1,856 		221 -0.7% 8.40 US$1,856
2025-10-06 2025-10-02 PlS Planned sale
Swanton Robert Charles
Non-Executive Director
102 -0.7%
8.55
US$872 		102 -0.7% 8.55 US$872
2025-10-06 2025-10-02 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
824 -0.7%
8.40
US$6,922 		824 -0.7% 8.40 US$6,922
2025-10-06 2025-10-02 PlS Planned sale
4.2
Young Alethia

Chief Financial Officer

Officer
265 -0.6%
8.61
US$2,280 		265 -0.6% 8.61 US$2,280
2025-10-06 2025-10-02 S Sale
4.2
Young Alethia

Chief Financial Officer

Officer
217 -0.5%
8.40
US$1,823 		217 -0.5% 8.40 US$1,823
2025-10-06 2025-10-02 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
1,147 -1.2%
8.40
US$9,635 		1,147 -1.2% 8.40 US$9,635
2025-10-06 2025-10-02 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
473 -0.9%
8.40
US$3,973 		473 -0.9% 8.40 US$3,973
2025-10-06 2025-10-02 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
2,263 -0.5%
8.40
US$19,009 		2,263 -0.5% 8.40 US$19,009
2025-10-02 2025-10-02 PrS Proposed sale
Swanton Robert Charles

Director

Non-Executive Director
102
8.55
US$872 		102 8.55 US$872
2025-10-02 2025-10-02 PrS Proposed sale
3.9
Thompson Travis Alvin

Officer

Officer
543
8.40
US$4,563 		543 8.40 US$4,563
2025-10-02 2025-10-02 PrS Proposed sale
3.9
Hannay Michael Charles Ferguson

Officer

Officer
755
8.40
US$6,344 		755 8.40 US$6,344
2025-10-02 2025-10-02 PrS Proposed sale
4.2
Young Alethia

Officer

Officer
486
7.09
US$3,447 		486 7.09 US$3,447
2025-10-02 2025-10-02 PrS Proposed sale
3.7
Lee Kevin

Officer

Officer
5,958
8.40
US$50,061 		5,958 8.40 US$50,061
2025-10-02 2025-10-02 PrS Proposed sale
3.8
Milnes Alistair

Officer

Officer
2,264
8.40
US$19,023 		2,264 8.40 US$19,023
2025-07-07 2025-07-03 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
3,193 -0.7%
7.44
US$23,756 		3,193 -0.7% 7.44 US$23,756
2025-07-07 2025-07-03 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
100 -0.3%
7.44
US$744 		100 -0.3% 7.44 US$744
2025-07-07 2025-07-03 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
248 -0.5%
7.44
US$1,845 		248 -0.5% 7.44 US$1,845
2025-07-07 2025-07-03 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
966 -0.8%
7.44
US$7,187 		966 -0.8% 7.44 US$7,187
2025-07-07 2025-07-03 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
966 -1.0%
7.44
US$7,187 		966 -1.0% 7.44 US$7,187
2025-07-07 2025-07-02 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
2,268 -0.5%
7.09
US$16,080 		2,268 -0.5% 7.09 US$16,080
2025-07-07 2025-07-02 S Sale
3.9
Thompson Travis Alvin

CHIEF ACCOUNTING OFFICER

Officer
206 -0.6%
7.09
US$1,461 		206 -0.6% 7.09 US$1,461
2025-07-07 2025-07-02 S Sale
4.2
Young Alethia

Chief Financial Officer

Officer
204 -0.4%
7.09
US$1,446 		204 -0.4% 7.09 US$1,446
2025-07-07 2025-07-02 S Sale
3.9
Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

Officer
474 -0.9%
7.09
US$3,361 		474 -0.9% 7.09 US$3,361
2025-07-07 2025-07-02 S Sale
3.7
Skynner Michael

CHIEF TECHNOLOGY OFFICER

Officer
825 -0.7%
7.09
US$5,849 		825 -0.7% 7.09 US$5,849
2025-07-07 2025-07-02 S Sale
3.8
Milnes Alistair

CHIEF OPERATING OFFICER

Officer
1,149 -1.2%
7.09
US$8,146 		1,149 -1.2% 7.09 US$8,146
2025-07-02 2025-07-02 PrS Proposed sale
4.2
Young Alethia

Officer

Officer
206
7.09
US$1,461 		206 7.09 US$1,461
2025-07-02 2025-07-02 PrS Proposed sale
3.9
Thompson Travis Alvin

Officer

Officer
530
7.09
US$3,760 		530 7.09 US$3,760
2025-07-02 2025-07-02 PrS Proposed sale
3.9
Hannay Michael Charles Ferguson

Officer

Officer
756
7.09
US$5,358 		756 7.09 US$5,358
2025-07-02 2025-07-02 PrS Proposed sale
3.8
Milnes Alistair

Officer

Officer
2,266
7.09
US$16,066 		2,266 7.09 US$16,066
2025-07-02 2025-07-02 PrS Proposed sale
3.7
Skynner Michael

Officer

Officer
1,942
7.09
US$13,769 		1,942 7.09 US$13,769
2025-07-02 2025-07-02 PrS Proposed sale
3.7
Lee Kevin

Officer

Officer
5,963
7.09
US$42,287 		5,963 7.09 US$42,287
2025-04-04 2025-04-03 S Sale
3.7
Lee Kevin

CHIEF EXECUTIVE OFFICER

Executive Director
3,432 -0.7%
7.48
US$25,671 		3,432 -0.7% 7.48 US$25,671
Explore more

More insider trading research around Bicycle Therapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America